Stock listing

Frankfurt:4MNA Minerva Neurosciences, Inc Aktie

German listing (Frankfurt) of Minerva Neurosciences, Inc · home listing NASDAQ:NERV

Follow Minerva Neurosciences, Inc into a list and get an email when it puts out news.

Share price · FWB:4MNA

€1.91 EUR -0.03 (-1.7%)

Close on Oct 30, 2026

Day range
€1.91 – €1.91 EUROct 30, 2026
Market cap
€91.20M EURAt the close on Oct 30, 2026 · price × 47.75M shares outstanding
Minerva Neurosciences, Inc logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:NERV · Home$2.32 USD+0.08 (+3.6%)394,310$2.27$2.32$1.96$2.24Close on Oct 30, 2026
Frankfurt:4MNA€1.91 EUR-0.033 (-1.7%)—€1.91€1.91€1.91€1.943Close on Oct 30, 2026
Ticker
Frankfurt:4MNA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
Frankfurt
Currency
EUR

What changed lately

Calls

Replays

  • Minerva Neurosciences (NASDAQ:NERV) Q3 2025 Earnings Call

    Thu, Nov 06, 2025 · 7:00 AM ET

    Watch Transcript
  • Minerva Neurosciences (NASDAQ:NERV) Q1 2023 Earnings Call

    Mon, May 15, 2023 · 8:30 AM ET

    Watch Transcript
  • Minerva Neurosciences (NASDAQ:NERV) Q4 2022 Earnings Call

    Wed, Mar 08, 2023 · 8:30 AM ET

    Watch Transcript

Latest news

All Minerva Neurosciences, Inc news

Decks

Minerva Neurosciences, Inc on 6ix

Sector
Health care
Industry
Biotechnology
News releases
16 in the last 12 months · 74 in all · newest Oct 29, 2026 · oldest 2019
Calls
9 calls with a replay · 9 with a transcript · latest Nov 6, 2025
Decks
20 decks · latest Sep 7, 2026

Where Minerva Neurosciences, Inc is listed

ListingExchangeCountryCurrency
NASDAQ:NERV · Home listingNASDAQUnited StatesUSD
LS Exchange:A3DMH5LS ExchangeGermanyEUR
Lang & Schwarz:A3DMH5Lang & SchwarzGermanyEUR
BOATS:NERVBOATSUnited StatesUSD
gettex:4MNAgettexGermanyEUR
Dusseldorf:4MNADusseldorfGermanyEUR
Frankfurt:4MNA · This pageFrankfurtGermanyEUR
Munich:4MNAMunichGermanyEUR
Stuttgart:4MNAStuttgartGermanyEUR
Tradegate:4MNATradegateGermanyEUR

Log in to ask 6ix AI your own questions about Minerva Neurosciences, Inc.